External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

jENS 2025

-
Coming soon
12:00 PM
Duration 90mins Belgrade, Serbia
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Pregnancy: The Prospective, Multicentre, Open-Label, Phase IV MINORE Study
Pietrasanta, Carlo; Bove, Riley; Dobson, Ruth; Oreja-Guevara, Celia; Derfuss, Tobias; McElrath, Thomas; Maillart, Elisabeth; Jacobs, Dina; Kletzl, Heidemarie; Kazlauskaite, Agne; Alves, Daniela; Raposo, Catarina; Craveiro, Licinio; Lin, Chien-Ju; Pasquarelli, Noemi; Vukusic, Sandra; Hellwig, Kerstin

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:45 PM
Duration 60mins Belgrade, Serbia
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Breastfeeding: The Prospective, Multicentre, Open-Label, Phase IV SOPRANINO Study
Pietrasanta, Carlo; Hellwig, Kerstin; Dobson, Ruth; Oreja-Guevara, Celia; Shah, Anna; Graham, Edith L; McElrath, Thomas; Kletzl, Heidemarie; Kazlauskaite, Agne; Alves, Daniela; Raposo, Catarina; Craveiro, Licinio; Lin, Chien-Ju; Pasquarelli, Noemi; Vukusic, Sandra; Bove, Riley

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar